MyAverix Finance
US · Healthcare
Lexaria Bioscience Corp (LEXX)
Biotechnology
Lexaria Bioscience Corp (LEXX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LEXX
Lexaria Bioscience Corp (LEXX) — FAQ
What is LEXX's P/E ratio?
The price-to-earnings (P/E) ratio for Lexaria Bioscience Corp (LEXX) is 25.00 (data as of 2026-05-23).
Does Lexaria Bioscience Corp pay a dividend?
Dividend yield is not available in the current snapshot for Lexaria Bioscience Corp (LEXX). Check the MyAverix Finance app for the latest dividend data.
What sector is Lexaria Bioscience Corp in?
Lexaria Bioscience Corp (LEXX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LEXX listed on?
LEXX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.